Analyst Price Targets — IDR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 12, 2025 2:25 pm | — | Roth Capital | $45.00 | $43.89 | TheFly | Idaho Strategic price target raised to $45 from $35 at Roth Capital |
| April 3, 2025 12:13 pm | Mike Niehuser | Roth Capital | $17.50 | $15.94 | TheFly | Idaho Strategic price target raised to $17.50 from $16.50 at Roth MKM |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for IDR

DRD, IDR and NAK could benefit as State Street sees gold reaching $5,000 by early 2027 and long-term drivers remain supportive after the recent pullback.

Idaho Strategic Resources (IDR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

IX, TTMI, ALB, IDR and PRM have been added to the Zacks Rank #1 (Strong Buy) List on June 29, 2026.

The No Surprises Act was created to protect patients from unexpected medical bills. While those patient protections are working, new research from the Elevance

BOSTON--(BUSINESS WIRE)--Zelis®, a leading provider of healthcare technology solutions, today announces Zelis NSA Claim Advantage℠, an AI-native solution designed to help health insurance payers manage rising Independent Dispute Resolution (IDR) complexity under the No Surprises Act (NSA). As dispute volume, compliance requirements and process deadlines pressure payer operations, Zelis NSA Claim Advantage brings…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for IDR.
U.S. House Trading
No House trades found for IDR.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
